Holds one active US DMF for caspofungin, filing since 2019. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF for caspofungin, filing since 2019. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF for caspofungin, filing since 2017. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF for caspofungin, filing since 2014. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 8 markets.
Holds one active US DMF for caspofungin, filing since 2013. Its 2024 FDA inspection closed as VAI.
Holds one active US DMF for caspofungin, filing since 2021.
Holds one active US DMF for caspofungin, filing since 2019. Its GMP is recognised in 1 market.
Holds one active US DMF for caspofungin, filing since 2019.
Registered with SFDA (Saudi Arabia) for caspofungin. Its 2019 FDA inspection closed as NAI.
Registered with SFDA (Saudi Arabia) for caspofungin.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for caspofungin and what filings they hold.
Chat with Fred, your AI analyst